Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (481-490 of 959) with videos related to

Pageof 96
Sort By:
ERJ Open Research|November 26, 2025
Drugs and toxins associated with pulmonary arterial hypertension: from established culprits to novel threatsJulien Grynblat, Alex Hlavaty, Laurent Savale, et al.
Journal of Global Health|March 21, 2025
Global distribution of prognostically significant pulmonary pressure indicative of pulmonary hypertensionGeoff A Strange, Bradley A Maron, Katarina Zeder, et al.
Respiratory Research|July 29, 2023
Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1Sharon Mumby, Frederic Perros, Julien Grynblat, et al.
The Lancet. Respiratory Medicine|March 16, 2016
A global view of pulmonary hypertensionMarius M Hoeper, Marc Humbert, Rogerio Souza, et al.
Anesthesiology|May 26, 2005
Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive casesMartine Bonnin, Frédéric J Mercier, Olivier Sitbon, et al.
The European Respiratory Journal|January 15, 2026
Severe Hypoxemia and Intrapulmonary Vascular Dilatations Associated with Long-Term Luspatercept TherapyMarina Gueçamburu, Pierre Schilfarth, Xavier Demant, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2008
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutationBenjamin Sztrymf, Florence Coulet, Barbara Girerd, et al.
Biologie Aujourd'Hui|October 1, 2016
[Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications]Ly Tu, Maria-Rosa Ghigna, Carole Phan, et al.
The European Respiratory Journal|October 23, 2020
Reversible pulmonary hypertension associated with multivisceral Whipple's diseaseAlice Camboulive, Etienne-Marie Jutant, Laurent Savale, et al.
Respiratory Research|July 18, 2020
In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expressionHélène Le Ribeuz, Audrey Courboulin, Maria-Rosa Ghigna, et al.
Pageof 96

Showing results (481-490 of 959) with videos related to

Sort By:
Pageof 96
ERJ Open Research|November 26, 2025
Drugs and toxins associated with pulmonary arterial hypertension: from established culprits to novel threatsJulien Grynblat, Alex Hlavaty, Laurent Savale, et al.
Journal of Global Health|March 21, 2025
Global distribution of prognostically significant pulmonary pressure indicative of pulmonary hypertensionGeoff A Strange, Bradley A Maron, Katarina Zeder, et al.
Respiratory Research|July 29, 2023
Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1Sharon Mumby, Frederic Perros, Julien Grynblat, et al.
The Lancet. Respiratory Medicine|March 16, 2016
A global view of pulmonary hypertensionMarius M Hoeper, Marc Humbert, Rogerio Souza, et al.
Anesthesiology|May 26, 2005
Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive casesMartine Bonnin, Frédéric J Mercier, Olivier Sitbon, et al.
The European Respiratory Journal|January 15, 2026
Severe Hypoxemia and Intrapulmonary Vascular Dilatations Associated with Long-Term Luspatercept TherapyMarina Gueçamburu, Pierre Schilfarth, Xavier Demant, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2008
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutationBenjamin Sztrymf, Florence Coulet, Barbara Girerd, et al.
Biologie Aujourd'Hui|October 1, 2016
[Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications]Ly Tu, Maria-Rosa Ghigna, Carole Phan, et al.
The European Respiratory Journal|October 23, 2020
Reversible pulmonary hypertension associated with multivisceral Whipple's diseaseAlice Camboulive, Etienne-Marie Jutant, Laurent Savale, et al.
Respiratory Research|July 18, 2020
In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expressionHélène Le Ribeuz, Audrey Courboulin, Maria-Rosa Ghigna, et al.
Pageof 96